Keyera Corp. (TSX: KEY) ("Keyera") announced today that it expects to release its year end 2024 results before markets open ...
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it has scheduled its fourth quarter and year-end 2024 financial results conference call and webcast for 1:30 p.m. Pacific Time (4:30 p.